Search results (26)
« Back to News & OpinionNews and Opinion from the Pandemic Sciences Institute at the University of Oxford
Researchers enrol record number of patients for landmark plague trial
26 April 2024
Research news Vaccines, treatments, diagnostics & trials
A randomised controlled trial to evaluate the efficacy and safety of treatments for bubonic plague has enrolled over 220 patients in Madagascar, marking a critical milestone in evidence generation for plague treatments.
Oxford hosts Belgian vaccine experts
28 March 2024
News Vaccines, treatments, diagnostics & trials
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
FCDO Minister meets with University of Oxford’s vaccine researchers
26 January 2024
Partner news Vaccines, treatments, diagnostics & trials
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
Vaccine trial for deadly Nipah virus launched
11 January 2024
Nipah virus Research news Vaccines, treatments, diagnostics & trials
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
New partnership aims to advance vaccine against MERS coronavirus
21 December 2023
Partner news Vaccines, treatments, diagnostics & trials
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats
12 December 2023
Partner news Vaccines, treatments, diagnostics & trials
New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.
Oxford welcomes global pandemic experts for focus on 100 Days Mission
2 November 2023
Partner news Vaccines, treatments, diagnostics & trials
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
2 November 2023
Research news Vaccines, treatments, diagnostics & trials
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
World-leading RECOVERY trial expands to investigate treatments for influenza
30 October 2023
Research news Vaccines, treatments, diagnostics & trials
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.
Conference brings together clinical researchers to explore lessons from COVID-19 for global research collaboration
16 October 2023
Events News Vaccines, treatments, diagnostics & trials
Clinical researchers and representatives from the World Health Organization defined a bold new path for global research collaboration in acute care at a conference co-hosted by ISARIC, a global federation of investigator-led clinical research networks.
Global collaboration to develop next-generation COVID-19 and flu vaccines
10 October 2023
News Research news Vaccines, treatments, diagnostics & trials
The University of Oxford has launched a new global vaccine collaboration, backed by £8 million funding from UK Research and Innovation (UKRI), and led by two PSI Principal Investigators.
Oxford and Liverpool scientists launch new vaccine trial for Middle East Respiratory Syndrome (MERS)
18 September 2023
News Research news Vaccines, treatments, diagnostics & trials
The UK trial is the next step in the development of a vaccine to protect people against MERS – a deadly viral illness with no current vaccines and the potential to cause a pandemic.
Clinical trial for Crimean-Congo haemorrhagic fever vaccine launched
11 September 2023
News Research news Vaccines, treatments, diagnostics & trials
A University of Oxford study has administered a new vaccine against tick-borne virus Crimean-Congo haemorrhagic fever (CCHF) to volunteers for the first time.
CEPI and University of Oxford to accelerate vaccine development against Disease X
30 August 2023
News Research news Vaccines, treatments, diagnostics & trials
The Coalition for Epidemic Preparedness Innovations (CEPI) and the University of Oxford have entered into a strategic partnership to accelerate the development of safe, effective and globally accessible vaccines to counter the threat of future pandemics.
Professor Sir Andrew Pollard reveals unique insights into the world of science in a new podcast
28 April 2023
News Vaccines, treatments, diagnostics & trials
Oxford Vaccine Group and Pandemic Sciences Institute’s Professor Pollard speaks to the people who shaped the COVID-19 pandemic in his new podcast, The Oxford Colloquy.
£12 million investment for Future Vaccines Manufacturing Hub
11 April 2023
News Research news Vaccines, treatments, diagnostics & trials
A new Future Vaccines Manufacturing Hub – co-led by University of Oxford and University College London – aims to make the UK the global centre for discovering and manufacturing next-generation vaccines.
Why diversity matters in vaccine science
10 February 2023
News Vaccines, treatments, diagnostics & trials
Professor Teresa Lambe sets out her advice for young scientists to mark the International Day of Women and Girls in Science.
Oxford’s RECOVERY trial team amongst MRC‘s Outstanding Team Impact prize finalists
9 December 2022
Awards Research news Vaccines, treatments, diagnostics & trials
The inaugural MRC Impact Prize recognises teams who have made outstanding impacts in health and medical research. The winners will be announced at a ceremony in the spring.
Oxford's Ebola vaccine recommended for deployment against Uganda outbreak
22 November 2022
News Research news Vaccines, treatments, diagnostics & trials
A vaccine developed by the Oxford Vaccine Group’s Prof Teresa Lambe and supported in clinical trials and manufacture scale-up by researchers from the Jenner Institute (Nuffield Department of Medicine) has been recommended for inclusion in a ring vaccination trial to combat a Sudan ebolavirus outbreak in Uganda.
PSI hosts GOARN UK Partners Day
9 November 2022
News Partner news Vaccines, treatments, diagnostics & trials
The Pandemic Sciences Institute is hosting the UK GOARN partners this week to discuss hot topics such as operational research and rapid response capacity during outbreaks.